Viewing Study NCT06052618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2026-01-28 @ 9:25 PM
Study NCT ID: NCT06052618
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2023-09-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None KSHV Inflammatory Cytokine Syndrome (KICS) View
None Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JAK2 View
None Interleukin-1 View
None interleukin 6 receptor View
None Lymphoproliferative Disorder View
None HIV View